Suchergebnisse - "Laterre, Pierre-François"

PubPharm (19)

1

Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19

enthalten in: BMC anesthesiology | 2023

von Henrie, J. | Gerard, L. | Declerfayt, C. | +5

2

Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19

enthalten in: BMC anesthesiology | 2023

von Henrie, J. | Gerard, L. | Declerfayt, C. | +5

3

Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19

enthalten in: BMC anesthesiology | 2023

von Henrie, J. | Gerard, L. | Declerfayt, C. | +5

4

Serum uric acid, disease severity and outcomes in COVID-19

enthalten in: Critical care (London, England) | 2021

von Dufour, I. | Werion, A. | Belkhir, L. | +27

5

Serum uric acid, disease severity and outcomes in COVID-19

enthalten in: Critical care | 2021

von Dufour, I. | Werion, A. | Belkhir, L. | +10

6

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation : the CONFIDENT trial protocol

enthalten in: BMC pulmonary medicine | 2020

von Misset, B. | Hoste, E. | Donneau, A. | +9

ErratumIn: BMC Pulm Med. 2021 Jul 26;21(1):248. - PMID 34311718

7

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol

enthalten in: BMC pulmonary medicine | 2020

von Misset, B. | Hoste, E. | Donneau, A. | +9

8

Impact of oversedation prevention in ventilated critically ill patients : a randomized trial-the AWARE study

enthalten in: Annals of intensive care | 2018

von SRLF Trial Group | de Jonghe, B. | Aboab, J. | +80

9

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

enthalten in: Critical care (London, England) | 2017

von Russell, J. | Vincent, J. | Kjølbye, A. | +6

10

Selepressin, a novel selective vasopressin $ V_{1A} $ agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

enthalten in: Critical care | 2017

von Russell, J. | Vincent, J. | Kjølbye, A. | +6